1. Shao C, Qiu Y, Liu J, Feng H, Shen S, Saiyin H, Yu W, Wei Y, Yu L, Su W, Wu J. PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability. Cell Death Dis. 2018 Aug 28;9(9):856.

2. Zhao Y, Hu X, Wei L, Song D, Wang J, You L, Saiyin H, Li Z, Yu W, Yu L, Ding J, Wu J.PARP10 suppresses tumor metastasis through regulation of Aurora A activity. Oncogene. 2018 May;37(22):2921-2935

3. Hu X, Zhao Y, Wei L, Zhu B, Song D, Wang J, Yu L, Wu J. CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis. Oncogene. 2017 Jul 13;36(28):4047-4059

4. Wang J, Zhu C, Xia R, Yu W, Dang Y, Fei Y, Yu L, Wu J. Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity. Cell Death Discovery (2017) 3, e17034;

5. Liu C*, Wu J*, Paudyal SC, You Z, Yu X. CHFR is important for the first wave of ubiquitination at DNA damage sites. Nucleic Acids Res. 2013 Feb 1;41 (3):1698-710. （*Co-First Author）

6. Wu J*, Liu C*, Chen J, Yu X. RAP80 protein is important for genomic stability and is required for stabilizing BRCA1-A complex at DNA damage sites in vivo. J Biol Chem. 2012 Jun 29;287(27):22919-26. （*Co-First Author）

7. Wu J, Chen Y Lu LY, Wu Y, Paulsen MT, Ljungman M, Ferguson DO, Yu X. Chfr and RNF8 synergistically regulate ATM activation. Nat Struct Mol Biol. 2011 Jun 26;18(7):761-8.

8. Wu J, Lu LY, Yu X. The role of BRCA1 in DNA damage response. Protein Cell. 2010 Feb;1(2):117-23. Review.

9. Wu J, Huen MS, Lu LY, Ye L, Dou Y, Ljungman M, Chen J, Yu X. Histone ubiquitination associates with BRCA1-dependent DNA damage response. Mol Cell Biol. 2009 Feb;29(3):849-60. 

10. Zhang F*, Ma J*, Wu J*, Ye L, Cai H, Xia B, Yu X. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol. 2009 Mar 24;19(6):524-9.（*Co-First Author）